Launch of new safety hypodermic needle

Covidien has announced that it is launching a new and improved Magellan Safety Hypodermic Needle.

The development of the new design, which gives clinicians more control and smoother activation of the safety shield, reflects Covidien's continued commitment to improving healthcare worker safety.

"We are transitioning to the new and improved Magellan Safety Needle technology as part of our strong and ongoing commitment to meeting the safety needs of our customers," said Jeff Hunt, President, Patient Care and Safety Products, Covidien. "As you may know, there is litigation under way related to the current Magellan Safety Needle technology used on our Magellan family of products. We are optimistic that the litigation will ultimately be resolved in our favor," Hunt added.

Covidien also announced that it has appealed a U.S. District Court jury finding in November 2007 that Covidien's current Magellan Safety Needle products infringed one of Becton Dickinson's patents and a subsequent judge's ruling granting Becton Dickinson's request for an injunction against Covidien's current Magellan Safety Needle product line. The injunction is scheduled to take effect on December 17, 2008. Over the next several weeks, Covidien will transition from its current line to its new and improved Safety Needle products.

"While we respect the judge's recent ruling in this matter, we believe our current product line does not infringe on Becton Dickinson's intellectual property," Hunt said. "Our number one priority is to ensure that our customers receive the very best in needle safety protection. We will continue to provide the best solutions in healthcare worker protection as we seamlessly transition to the new and improved Magellan Safety Needles."

Net sales of the Magellan product line were less than $35 million in fiscal 2008.


The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
You might also like... ×
New research identifies factors that contribute to racial disparity in healthcare systems